Valentin Garcia Gutiérrez, MD, PhD, Hospital Universitario Ramón y Cajal, Madrid, Spain, emphasizes the importance of being aware of the side effects associated with each of the available tyrosine kinase inhibitors (TKIs) in order to select the most appropriate TKI for each patient. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Research funding, speaking engagements, ad boards: Novartis, BMS, Incyte, Pfizer